A. Schmidt, V. A. Diwadkar, and R. Smieskova, Approaching a network connectivity-driven classification of the psychosis continuum: a selective review and suggestions for future research, Front Hum Neurosci, vol.8, p.1047, 2014.

L. C. Johns and J. Van-os, The continuity of psychotic experiences in the general population, Clin Psychol Rev, vol.21, issue.8, pp.1125-1141, 2001.

R. J. Linscott and J. Van-os, An updated and conservative systematic review and meta-analysis of epidemiological evidence on psychotic experiences in children and adults: on the pathway from proneness to persistence to dimensional expression across mental disorders, Psychol Med, vol.43, issue.6, pp.1133-1149, 2013.

D. E. Job, H. C. Whalley, S. Mcconnell, M. Glabus, E. C. Johnstone et al., Structural gray matter differences between first-episode schizophrenics and normal controls using voxel-based morphometry, NeuroImage, vol.17, issue.2, pp.880-889, 2002.

I. Nenadic, M. Dietzek, and N. Schonfeld, Brain structure in people at ultra-high risk of psychosis, patients with first-episode schizophrenia, and healthy controls: a VBM study, Schizophr Res, vol.161, issue.2-3, pp.169-176, 2015.

G. K. Tzilos, C. B. Cintron, and J. B. Wood, Lack of hippocampal volume change in long-term heavy cannabis users, Am J Addict, vol.14, issue.1, pp.64-72, 2005.

M. Yucel, N. Solowij, and C. Respondek, Regional brain abnormalities associated with long-term heavy cannabis use. Arch Gen Psychiatry, vol.65, pp.694-701, 2008.

H. D. Burns, K. Van-laere, and S. Sanabria-bohorquez, MK-9470, a positron emission tomography (PET) tracer for in vivo human PET brain imaging of the cannabinoid-1 receptor, Proceedings of the National Academy of Sciences of the United States of America, vol.18, pp.9800-9805, 2007.

L. Koenders, V. Lorenzetti, and L. De-haan, Longitudinal study of hippocampal volumes in heavy cannabis users, Journal of psychopharmacology, vol.31, issue.8, pp.1027-1034, 2017.

G. Schumann, E. Loth, and T. Banaschewski, The IMAGEN study: reinforcement-related behaviour in normal brain function and psychopathology. Mol Psychiatry, vol.15, pp.1128-1139, 2010.

N. Mossaheb, J. Becker, and M. R. Schaefer, The Community Assessment of Psychic Experience (CAPE) questionnaire as a screening-instrument in the detection of individuals at ultra-high risk for psychosis, Schizophr Res, vol.141, issue.2-3, pp.210-214, 2012.

, Cannabis-Associated Psychotic-Like Experiences Are Mediated by Developmental Changes in the Parahippocampal Gyrus RH=Cannabis-Associated PLEs Mediated by Parahippocampus

T. Yu and P. Md, 5# Tianye Jia, p.1, 2004.

L. W. Arun and . Bokde, PhD, p.7

E. Burke-quinlan, PhD, 2 Andreas Heinz, MD, PhD, 13 Bernd Ittermann, p.14

, Decheng Ren, PhD, p.1

L. Du, PhD, 4 Binyin Hou, PhD, 1 Herta Flor, p.10

H. Garavan, P. Phd, and . Gowland, , p.15

M. Martinot and P. Md, 15 Frauke Nees, PhD, 8 Dimitri Papadopoulos Orfanos, PhD, 10 Qiang Luo, p.16

L. Poustka and . Md,

N. Michael,

M. D. Smolka and N. C. Vetter, , p.13

J. H. Fröhner, MSc, 17 Robert Whelan, PhD, 18 Guang He, 1920.

G. Schumann, . Md, . Phd, and . Robert, 3* and the IMAGEN Consortium ?

-. Bio and . Institutes,

, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Medical Research Council -Social

B. Behavior and . Ganglia-unit,

, Shanghai Center for Women and Children's Health

, Jining Medical University

, School of Social Sciences

C. Neurospin, C. Atomique, and U. Paris-saclay,

P. Bundesanstalt,

, School of Psychology and Global Brain Health Institute

, Baoan Maternal and Child Health Hospital

, ? IMAGEN consortium authors, affiliations and acknowledgement are listed in the supplementary materials

, # Both authors should be considered co-first authors * Both authors should be considered co-corresponding authors Correspondence should be addressed to Gabriel Robert (Email: gabriel.hadrien.robert@gmail.com) or Gunter Schumann

, This work received support from the following sources: the European Union-funded FP6 Integrated Project IMAGEN (Reinforcement-related behavior in normal brain function and psychopathology, 602450.

, 115300-2), the Medical Research Council Grants "Developmental pathways into adolescent substance abuse" (93558) and Consortium on Vulnerability to Externalizing Disorders and Addictions, IMAging GEnetics for MENtal Disorders), AGGRESSOTYPE (602805) and MATRICS (603016), Sanming Project of Medicine in Shenzhen (No. SZSM201406007), the Innovative Medicine Initiative Project EU-AIMS

, the Fourth Round of Shanghai Three-year Action Plan on Public Health Discipline and Talent Program: Woman and Children's Health (No.15GWZK0401), the Shanghai Key Laboratory of Psychotic Disorders (13dz2260500), the 111 Project (B18015); the NSFC (81801773), the key project of Shanghai Science and Technology (16JC1420402), the Shanghai Municipal Science and Technology Major Project (No. 2018SHZDZX01), ZJLAB, and the Shanghai Pujiang Project (18PJ1400900), the Deutsche Forschungsgemeinschaft (DFG grants SM 80/7-1, SM, vol.80, pp.1-0711

, Paris Sud University IDEX 2012, the National Institutes of Health, USA (Axon, Testosterone and Mental Health during Adolescence; RO1 MH085772-01A1), and by NIH Consortium grant U54 EB020403, supported by a cross-NIH alliance that funds Big Data to Knowledge Centers of Excellence. Dr. Gabriel Robert was funded by the Fondation pour la Recherche Médicale (SPE20130326586), the Fondation Pierre Deniker, the Centre Hospitalier Guillaume Régnier, the Scientific Institut Servier

, The IMAGEN Consortium consists of: Dr. Michael Rapp, Charite; Dr. Eric Artiges, INSERM

C. Bach, Central Institute of Mental Health

A. Barbot, Commissariat à l'Energie Atomique, Prof. Dr. Gareth Barker

A. Dr and . Bokde, Trinity College Dublin; Dr. Nora Vetter

. Prof, . Dr, . Christian, and . Büchel, University of Hamburg; Dr. Anna Cattrell, King's College London

H. Dr and . Crombag,

K. Czech, ;. Charite, and . Dr,

J. Dalley,

B. Decideur,

B. Fuchs, . Gabo:-milliarium, . Mbh, . Co, . J. Kg;-dr et al., Trinity College Dublin; Prof. Dr. Rainer Spanagel, Central Institute of Mental Health, Deutsches Referenzzentrum für Ethik; Prof. Dr. Andreas Heinz

T. Dr and . Jia,

A. Ihlenfeld, P. Ireland, ;. Delosis, . Dr, . Bernd-ittermann et al.,

. Prof, . Dr, . Tobias, and . Banaschewski, Trinity College Dublin; Dr. Arno Klaassen, Scito; Christophe Lalanne, Commissariat à l'Energie Atomique; Dr. Dirk Lanzerath, Deutsches Referenzzentrum für Ethik; Dr

C. Mallik, King's College London; Prof. Dr. Karl Mann, Central Institute of Mental Health

. Dr and . Adam,

L. Martinez-medina,

. Dr, I. Jean-luc-martinot, and . Mennigen, Technische Universität Dresden; Dr. Fabiana Mesquita de Carvahlo, King's College London; Yannick Schwartz, Commissariat à l'Energie Atomique; Dr. Ruediger Bruehl, PTB; Kathrin Müller

, Frauke Nees, Central Institute of Mental Health

C. Nymberg, King's College London

Z. Dr and . Pausova,

J. Dr, . Pentilla, . F. Insermiertee;-dr, and . Biondo,

J. Poline,

S. Dr and . Hohmann,

S. Millenet, Central Institute of Mental Health

. Prof, . Dr, and . Smolka,

J. Fröhner,

M. Dr and . Struve, Central Institute of Mental Health

. Prof and . Dr,

T. Dr and . Hübner,

S. Aydin, P. Rogers, D. Romanowski, ;. Charite, C. Dr et al.,

D. Schmidt,

S. Ripke,

F. Dr, . Schubert, Y. Ptb;-dr, and . Pena-oliver,

X. Mignon, . R. Pertimm;-dr, and . Whelan,

C. Dr, . Speiser, . Gabo:milliarium, . Mbh, . Co et al.,

A. Dr, . Ströhle, ;. Charite, . Dr, I. Marie-laure-paillere et al.,

S. Jurk, Technische Universität Dresden; Dr

H. Vulser, . Inserm;-ruben, . Miranda, . J. Inserm;-dr, and . Yacubilin,

V. Frouin, Commissariat à l'Energie Atomique

A. Genauck, C. Parchetka, C. Gemmeke, C. Kruschwitz, C. Weib et al.,

J. Feng,

D. Papadopoulos, I. Filippi, and I. Ing,

B. Xu,

C. Macare, . C. King's-college-london;-dr, and . Chu, King's College London; Eanna Hanratty, King's College London; Dr

G. Dr and . Robert, King's College London

T. Dr and . Yu,

V. Ziesch,

A. Stedman,

H. Pharma, . Bristol-myers, D. Squibb, E. Arzneimittel, . Lilly et al., He has received conference attendance support, conference support, or speaking fees from Eli Lilly, Janssen McNeil, Medice, Novartis, Shire, and UCB. He is involved in clinical trials conducted by Eli Lilly, Novartis, Shire, and Viforpharma. He has received royalties from Hogrefe, Disclosure: Dr. Banaschewski has served as an advisor or consultant to Actelion